Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): A randomised controlled superiority trial

The Lancet

Volumn 378, Issue 9796, 2011, Pages 1071-1078

  Mehilli, Julinda ^a   Pache, Jürgen ^a   Abdel Wahab, Mohamed ^d   Schulz, Stefanie ^a   Byrne, Robert A ^a   Tiroch, Klaus ^c   Hausleiter, Jörg ^a   Seyfarth, Melchior ^c   Ott, Ilka ^a   Ibrahim, Tareq ^b   Fusaro, Massimiliano ^a   Laugwitz, Karl Ludwig ^b   Massberg, Steffen ^a   Neumann, Franz Josef ^e   Richardt, Gert ^d   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Helios Clinics Wuppertal   (Germany)

^d Herzzentrum der Segeberger Kliniken   (Germany)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; POLYMER; RAPAMYCIN;

AGED; ANGINA PECTORIS; ARTICLE; BARE METAL STENT; BIODEGRADABILITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DRUG ELUTING STENT; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; TREATMENT OUTCOME;

EID: 80052962442     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61255-5     Document Type: Article

References (30)

1. GM Fitzgibbon, HP Kafka, AJ Leach, WJ Keon, GD Hooper, JR Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626 (Pubitemid 26288642)
2. MK Hong, R Mehran, G Dangas et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results J Am Coll Cardiol 38 2001 150 154 (Pubitemid 32613842)
3. DA Morrison, G Sethi, J Sacks et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients J Am Coll Cardiol 40 2002 1951 1954 (Pubitemid 35425365)
4. WS Weintraub, EL Jones, DC Morris, SB King 3rd, RA Guyton, JM Craver Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery Circulation 95 1997 868 877 (Pubitemid 27091527)
5. MP Savage, JS Douglas Jr, DL Fischman et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators N Engl J Med 337 1997 740 747 (Pubitemid 27417973)
6. MA Mamas, J Foley, S Nair et al. A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis J Interv Cardiol 24 2011 172 180
7. A Kastrati, J Mehilli, J Pache et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
8. RA Byrne, N Sarafoff, A Kastrati, A Schomig Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment Drug Saf 32 2009 749 770
9. C Stettler, S Wandel, S Allemann et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
10. ES Brilakis, TY Wang, SV Rao et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry JACC Cardiovasc Interv 3 2010 1068 1073
11. P Vermeersch, P Agostoni, S Verheye et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts. Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trail J Am Coll Cardiol 48 2006 2423 2431 (Pubitemid 44895571)
12. ES Brilakis, C Lichtenwalter, JA de Lemos et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
13. P Vermeersch, P Agostoni, S Verheye et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial J Am Coll Cardiol 50 2007 261 267 (Pubitemid 47039289)
14. ES Brilakis, C Lichtenwalter, AR Abdel-karim et al. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial JACC Cardiovasc Interv 4 2011 176 182
15. R Hoffmann, GS Mintz, JJ Popma et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries J Am Coll Cardiol 28 1996 1134 1139 (Pubitemid 26376985)
16. C Depre, X Havaux, W Wijns Pathology of restenosis in saphenous bypass grafts after long-term stent implantation Am J Clin Pathol 110 1998 378 384 (Pubitemid 28406997)
17. RA Byrne, A Kastrati, S Kufner et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial Eur Heart J 30 2009 2441 2449
18. L Ge, I Iakovou, GM Sangiorgi et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome J Am Coll Cardiol 45 2005 989 994 (Pubitemid 40432427)
19. SL Zeger, KY Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
20. P Grambsch, TA Louis, RM Bostick et al. Statistical analysis of proliferative index data in clinical trials Stat Med 13 1994 1619 1634 (Pubitemid 24275841)
21. MH Shishehbor, R Hawi, IM Singh et al. Drug-eluting versus bare-metal stents for treating saphenous vein grafts Am Heart J 158 2009 637 643
22. A Coolong, DS Baim, RE Kuntz et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients Circulation 117 2008 790 797 (Pubitemid 351640680)
23. BR Brodie, H Wilson, T Stuckey et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group JACC Cardiovasc Interv 2 2009 1105 1112
24. MS Lee, T Yang, DE Kandzari, JM Tobis, H Liao, E Mahmud Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention Am J Cardiol 105 2010 1076 1082
25. D Joyal, J Afilalo, S Rinfret Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis Am Heart J 160 2010 179 187
26. RC Ali, C Melloni, FS Ou et al. Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time J Am Geriatr Soc 57 2009 1990 1996
27. LK Newby, NM LaPointe, AY Chen et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
28. DS Baim, D Wahr, B George et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290 (Pubitemid 34260417)
29. AJ Bryan, GD Angelini The biology of saphenous vein graft occlusion: etiology and strategies for prevention Curr Opin Cardiol 9 1994 641 649 (Pubitemid 24341152)
30. JG Webb, RG Carere, R Virmani et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention J Am Coll Cardiol 34 1999 468 475